
    
      -  Open-label, non-inferiority, prospective, parallel group, intent to treat trial.

        -  Experiment duration: 56 days.

        -  04 visits (days -7, 0, 28 and 56).

        -  Efficacy will be evaluated for 10 episodes of tension-type headache.

        -  Adverse events evaluation.
    
  